UNSPSC 51162510: Dextromethorphan/glycerol, iodinated

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE302. This VA Drug Class (RE302) classifies this compound as belonging to the group NON-OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51162510 Dextromethorphan/glycerol, iodinated is a Commodity code that encompasses pharmaceutical products and OTC items procured by state and local health agencies, county health departments, and multistate cooperative purchasing alliances. State and local governments under this code buy generic pharmaceuticals, over-the-counter medications, and related health products for distribution through county health facilities, community health centers, and participating state and local government facilities across multiple jurisdictions. The issuing bodies include county health departments (such as Seminole County, Florida) and state-led multistate cooperative purchasing alliances that aggregate demand across dozens of participating jurisdictions to leverage volume pricing and standardized supplier relationships.

Recent activity shows two distinct procurement models. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to its Community Health Building; the bid deadline was July 26, 2023, with electronic submission required through the county's e-Procurement Portal. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota, Oregon, and other member jurisdictions; the RFP response deadline was March 26, 2026, with contract effective dates of July 1, 2026 for new awards. Geographic activity centers on Florida and the upper Midwest (Minnesota, Oregon, and MMCAP member states). Both opportunities require vendors to meet FDA compliance, cGMP certification, DSCSA compliance, and specific insurance requirements including commercial general liability coverage.